GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » EKF Diagnostics Holdings PLC (OTCPK:EKDHF) » Definitions » Capex-to-Revenue

EKF Diagnostics Holdings (EKF Diagnostics Holdings) Capex-to-Revenue : 0.14 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is EKF Diagnostics Holdings Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

EKF Diagnostics Holdings's Capital Expenditure for the six months ended in Dec. 2023 was $-4.42 Mil. Its Revenue for the six months ended in Dec. 2023 was $32.58 Mil.

Hence, EKF Diagnostics Holdings's Capex-to-Revenue for the six months ended in Dec. 2023 was 0.14.


EKF Diagnostics Holdings Capex-to-Revenue Historical Data

The historical data trend for EKF Diagnostics Holdings's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EKF Diagnostics Holdings Capex-to-Revenue Chart

EKF Diagnostics Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.04 0.07 0.09 0.13

EKF Diagnostics Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.08 0.10 0.13 0.14

Competitive Comparison of EKF Diagnostics Holdings's Capex-to-Revenue

For the Medical Devices subindustry, EKF Diagnostics Holdings's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EKF Diagnostics Holdings's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, EKF Diagnostics Holdings's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where EKF Diagnostics Holdings's Capex-to-Revenue falls into.



EKF Diagnostics Holdings Capex-to-Revenue Calculation

EKF Diagnostics Holdings's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-8.829) / 66.596
=0.13

EKF Diagnostics Holdings's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-4.42) / 32.581
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EKF Diagnostics Holdings  (OTCPK:EKDHF) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


EKF Diagnostics Holdings Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of EKF Diagnostics Holdings's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


EKF Diagnostics Holdings (EKF Diagnostics Holdings) Business Description

Traded in Other Exchanges
Address
19 Stanwell Road, Penarth, Avon House, Cardiff, GBR, CF64 2EZ
EKF Diagnostics Holdings PLC is engaged in the field of medical diagnostics. The company's core business is point-of-care testing and manufacturing reagents for use in central laboratories. It caters to companies focused on areas such as diabetes, blood banking, and sports medicine. The company derives its income from its sales in the United States. Its other markets include Germany, Poland, and Russia.

EKF Diagnostics Holdings (EKF Diagnostics Holdings) Headlines

From GuruFocus